LON:OVB

Ovoca Bio (OVB) Share Forecast, Price & News

GBX 10.50

-0.25 (-2.33%)

(As of 05/27/2022 03:16 PM ET)

Add

Compare

Today's Range: 10.19
▼
10.50
50-Day Range: 9.77
▼
14.85
52-Week Range: 8.15
▼
26

Volume: 79,009 shs
Average Volume: 172,409 shs
Market Capitalization: £8.56 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive OVB News and Ratings via Email

Sign-up to receive the latest news and ratings for Ovoca Bio and its competitors with MarketBeat's FREE daily newsletter.

About Ovoca Bio

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.

February 25, 2022 | reuters.com

OVB.I - Ovoca Bio PLC Profile | Reuters

June 26, 2020 | www.lse.co.uk

Ovoca Bio Annual Loss Slightly Narrows; Capital Base "Strong"

May 1, 2020 | www.lse.co.uk

Ovoca Bio Share Chat

March 26, 2020 | www.lse.co.uk

Ovoca Bio Share Price (OVB)

March 26, 2020 | www.lse.co.uk

Ovoca Bio Regulatory News

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:OVB
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.ovocabio.com
Phone: 353 1 661 9819
Fax: N/A
Employees: 5
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 10.64 per share
Price / Cash Flow: 0.99
Book Value: GBX 20 per share
Price / Book: 0.53

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 4.80
Current Ratio: 7.62
Quick Ratio: 7.29

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 81,564,000
Free Float: N/A
Market Cap: £8.56 million
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.06 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Ovoca Bio.

4.7 Community Rank

Outperform Votes
Ovoca Bio has received 17 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Ovoca Bio has received 7 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Ovoca Bio has received 70.83% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Ovoca Bio and other stocks. Vote “Outperform” if you believe OVB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OVB will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Ovoca Bio does not currently pay a dividend.
Dividend Growth
Ovoca Bio does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ovoca Bio insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Ovoca Bio is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Ovoca Bio is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Ovoca Bio has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ovoca Bio (LON:OVB) Frequently Asked Questions

Who are Ovoca Bio's key executives?: Ovoca Bio's management team includes the following people:
Mr. Kirill Andreyevich Golovanov, Interim Chairman & CEO (Age 44, Pay $199.72k)
Mr. Dmitriy Nikitashenko, VP of Fin.
Dr. Daniil Nemenov, Sr. VP of Clinical Devel. & Operations
Reneta Nikolova, Corp. Sec.
Who are some of Ovoca Bio's key competitors?: Some companies that are related to Ovoca Bio include Neptune Wellness Solutions (NEPT), Destiny Pharma (DEST), Tissue Regenix Group (TRX), Collagen Solutions plc (COS.L) (COS), Helix BioPharma (HBP), Liberty Biopharma (LTY), OptiBiotix Health (OPTI), Hemostemix (HEM), AorTech International (AOR), ReNeuron Group (RENE), NetScientific (NSCI), Bioasis Technologies (BTI), Oxford BioDynamics (OBD), IXICO (IXI) and Ensysce Biosciences (ENSC).
View all of OVB's competitors.
What other stocks do shareholders of Ovoca Bio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ovoca Bio investors own include CarMax (KMX), Beazer Homes USA (BZH), Chesapeake Lodging Trust (CHSP), Mitie Group (MTO), New World Development (NDVLY), Parsley Energy (PE), Bilibili (BILI), Bango (BGO), Belmont Resources (BEA) and BioDelivery Sciences International (BDSI).
What is Ovoca Bio's stock symbol?: Ovoca Bio trades on the London Stock Exchange (LON) under the ticker symbol "OVB."
How do I buy shares of Ovoca Bio?: Shares of OVB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Ovoca Bio's stock price today?: One share of OVB stock can currently be purchased for approximately GBX 10.50.
How much money does Ovoca Bio make?: Ovoca Bio has a market capitalization of £8.56 million.
How many employees does Ovoca Bio have?: Ovoca Bio employs 5 workers across the globe.
What is Ovoca Bio's official website?: The official website for Ovoca Bio is www.ovocabio.com.
How can I contact Ovoca Bio?: The company can be reached via phone at 353 1 661 9819.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.